Huadi Yang

Dr. Huadi Yang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in BioMed Research International
Verified
Journal Article
Open access
PDF file
HYHuadi Yang
Huadi Yang
HLHui Li
Hui Li
SLShenyi Lu
Shenyi Lu
SSShuangshuang Shan
Shuangshuang Shan
YGYong Guo
Yong Guo
Objectives. This study is aimed at investigating the anticancer activity of Fuzheng Jiedu decoction (FJD) alone or in combination with cisplatin in ovarian cancer (OC) models, as well as its underlying mechanisms of action. Methods. The anticancer activities of FJD, cisplatin, and the combination of the PI3K inhibitor (LY294002, LY) or activator (IGF‐1) were evaluated in OC cell lines in vitro and in a SKOV3 xenograft mouse model in vivo. The cell proliferation and invasion ability were measured using MTT, EdU, and transwell assays, respectively. The cell apoptosis was examined by flow cytometry and JC‐1 assays. The expression levels of the Bcl‐2 family and the PI3K/AKT/mTOR/NF‐κB pathway‐related proteins were analyzed by Western blot. Results. The in vivo and in vitro studies showed that FJD administration could significantly inhibit cell proliferation and promote cell apoptosis in two OC cell lines SKOV3 and 3AO and partially decreased the tumor volumes and weights. In addition, FJD could significantly downregulate the protein levels of p‐PI3K/PI3K, p‐AKT/AKT, p‐mTOR/mTOR, NF‐κB, p38, and Bcl‐2 and upregulate the Bax, Cyt‐C, and cleaved caspase‐3 in OC tumor tissues and cells. FJD cotreatment increased the efficacy of cisplatin, including inhibiting OC cell proliferation and invasion, promoting cell apoptosis, and inhibiting the PI3K/AKT/mTOR signaling pathway, while this enhancement was suppressed by IGF‐1. Similarly, LY also enhanced the anticancer efficacy of cisplatin. Conclusions. This study indicated that FJD could improve the efficacy of cisplatin by inhibiting the PI3K/AKT/mTOR/NF‐κB signaling pathway. It is suggested that FJD may be a valuable adjuvant drug for the treatment of OC.

21 April 2023 in Medicine
Verified
Journal Article
Open access
PMPeiyu Mm Mao
Peiyu Mm Mao
CZChen Mm Zhang
Chen Mm Zhang
XWXinyan Mm Wang
Xinyan Mm Wang
HYHuadi Yang
Huadi Yang
Rationale: Copious vaginal discharge is a frequent manifestation of reproductive tract infections. However, when little effect can obtain treated as vaginitis, cervical disease should be highly suspected. Patient concerns: A 41-year-old woman had suffering from abnormally increased vaginal discharge without any other signs of discomfort for the past 4 years. A lot of medical examinations and treatment of vaginosis were administered, resulting in unclear diagnosis and little effect. Diagnoses: Cervical adenocarcinoma. Interventions: Gynecological examination, vaginal microbiome culture, and primary cervical cancer screening were negative, and a positron emission tomography revealed an increased 18F-fluorodeoxyglucose metabolism in the local cervix. After a thorough description, the patient demanded a hysterectomy and bilateral salpingo-oophorectomy. Outcomes: Histopathological evaluation confirmed adenocarcinoma in situ of the uterine cervix. Lessons: The correct diagnosis of symptomatic patients with increased vaginal discharge is challenging. Human papillomavirus-negative patients presenting profuse watery vaginal discharge with an abnormal signal of cervix lesion on positron emission tomography or magnetic resonance imaging should be alert to cervical adenocarcinoma. Deep-seated cervical biopsy, conization, or even hysterectomy is conducive to early diagnosis, treatment and improvement of prognosis.

9 September 2022 in Medicine
Verified
Journal Article
Open access
HYHuadi Yang
Huadi Yang
XJXuelu Bm Jiang
Xuelu Bm Jiang
TCTing Mm Chen
Ting Mm Chen
ZYZhitao Yao
Zhitao Yao
XXXuqun Bm Xu
Xuqun Bm Xu
XZXiaojing Mm Zhu
Xiaojing Mm Zhu
To evaluate the feasibility and efficiency of our novel technique, ultrasound guided hysteroscopic catheter dilation (US-HCD), for the treatment of moderate to severe intrauterine adhesion (IUA). A total of 126 patients diagnosed with IUA and met the enrollment criteria were admitted in this historical cohort study from June 1, 2016 to December 31, 2018. All patients were divided into 2 groups according to the surgical techniques used. Group A (n = 68) were treated with traditional hysteroscopic adhesiolysis with scissors (THA) and Group B (n = 58) were treated with US-HCD. Their data for the next 2 years following the initial surgery were analyzed. Safety and feasibility (operation time, surgical complications and the third-look hysteroscopic surgery rate), and post-operation efficacy (reduction of American Fertility Society [AFS] scores, pregnancy and live birth rates) were evaluated between groups. Between the groups, there was no statistically significant differences in basic preoperative information and AFS scores (P > .05). While there were significant differences in the operation time of the initial surgery (P < .05) and reduction of AFS scores (P < .05). No surgical complications were recorded and only 3 patients (5.2%) received a third-look hysteroscopy in Group B, while there were 6 cases of complications and 13 cases (19.1%) of third-look hysteroscopy in Group A, indicating significant differences between Groups (P < .05). Both groups exhibited comparable pregnancy rate, live birth rate and obstetric complications (P > .05). Our new technique is a safe, feasible and effective procedure for moderate to severe IUA patients, which can be mastered more quickly and easily by surgeons and applied in areas with less affluent economy and without hysteroscopic scissors, thus worthy of further study.

19 November 2024 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
PMPeiyu Mao
Peiyu Mao
WMWeijie Meng
Weijie Meng
TMTongxin Mao
Tongxin Mao
HLHui Li
Hui Li
XXXuqun Xu
Xuqun Xu
HYHuadi Yang
Huadi Yang
Background: Pain and gastrointestinal dysfunction after laparoscopic myomectomy (LM) are significant issues that prevent this procedure from being classified as a “Day Surgery.” This study aims to assess the effectiveness and safety of thumbtack needle acupuncture (TNA) combined with patient-controlled intravenous analgesia (PCIA) for promoting enhanced recovery after LM.Methods: A total of 52 patients were enrolled in the study, divided into a treatment group receiving TNA and a control group. Both groups were administered PCIA without background sufentanil. For rescue analgesia or antiemetic needs, a bolus infusion of flurbiprofen axetil (50 mg) or intravenous metoclopramide (10 mg) was provided. The primary outcomes measured were the Visual Analog Scale (VAS) scores at awakening, as well as at 36 h, 48 h, and 60 h after LM. Secondary outcomes included VAS scores at 6 h, 12 h, 24 h, and 72 h after LM, total sufentanil consumption, the number of PCIA analgesic requests (attempts), the number of doses of rescue flurbiprofen axel analgesia required, preoperative anxiety scores, gastrointestinal function recovery assessment, first ambulation time, length of hospital stay, and patient satisfaction. Adverse events were also recorded.Results: Compared to the control group, the treatment group showed significantly lower VAS scores, fewer analgesia attempts, reduced total sufentanil consumption, and a smaller number of rescue analgesia doses after LM, along with lower preoperative anxiety scores and higher satisfaction with pain management (p < 0.05). Gastrointestinal function recovery was enhanced in the treatment group, as indicated by earlier flatus and defecation, a lower incidence of postoperative nausea and vomiting (PONV), and a smaller number of metoclopramide doses required (p < 0.05). Additionally, ambulation occurred earlier, and the length of hospital stay was shorter in the treatment group (p < 0.05). No adverse events were observed in patients receiving TNA.Conclusion: TNA is a safe intervention that effectively alleviates postoperative pain, decreases the total consumption of sufentanil, reduces preoperative anxiety, enhances the recovery of gastrointestinal function, and shortens the duration of hospitalization, making it an ideal adjunct treatment for postoperative recovery after LM. Further research is required to understand the mechanisms underlying this intervention.Clinical trial registration: www.chictr.org.cn, ChiCTR2300069015.

18 April 2025 in Medicine
Verified
Journal Article
Open access
SLShenyi Mm Lu
Shenyi Mm Lu
HYHuadi Yang
Huadi Yang
PMPeiyu Mm Mao
Peiyu Mm Mao
GCGuiping Bd Chen
Guiping Bd Chen
Rationale: Radical hysterectomy is the standard surgical procedure for early-stage cervical cancer, and postoperative adjuvant chemoradiotherapy is administered based on pathological high-risk and intermediate-risk factors. After treatment of cervical cancer, all focus is placed on postoperative recurrence, metastasis and menopausal symptoms, and almost no one pays attention to the recovery of vaginal elasticity and sexual activity of reproductive-age women. Due to frequent surgery and radiation therapy for cervical cancer patients, the length and elasticity of the vagina are reduced. Cervical cancer patients need to be aware of issues related to sexual activity, such as vaginal shortening or shrinking, the impact of cancer on sexuality, and when to restore sexual activity after surgery. Patients who receive this information can better cope with these changes. We report a clinical case with the aim of sharing our experiences and calling for an emphasis on the recovery of vaginal stump and vaginal elasticity and sexual activity guidance after radical hysterectomy. Patient concerns: A 48-year-old woman with cervical cancer who underwent radical hysterectomy 6 years ago was admitted to the gastrointestinal surgery ward urgently, having shown severe upper abdominal pain accompanied 6 hours after sex activity. Diagnoses: Small bowel vaginal hernia with intestinal necrosis was diagnosed. Interventions: Urgent surgery was performed to resect the necrotic small intestine and repair the vaginal stump and pelvic floor. Outcomes: After surgery, she recovered well and is currently under regular follow-up for cervical cancer. Lessons: It is crucial to regularly guide and follow-up on patients’ sexual behavior during the follow-up period after cervical cancer surgery. Gynecologists should fully inform the time for restoring sexual relations after cervical cancer surgery. Nursing staff should be guided to avoid premature and excessive sexual activity to the vaginal cuff to prevent rupture and other potential complications. Effective medical intervention should be implemented as early as possible for patients with vaginal sac rupture after cervical cancer surgery. Current research on sexual activity after cervical cancer surgery has many limitations and more detailed studies are needed. A specific questionnaire to assess sexual activity and a clinical study to determine the appropriate medication to restore vaginal elasticity are expected.